CELSO
ARANGO LÓPEZ
Catedrático de universidad
Eli Lilly and Company
Indianapolis, EE. UU.Publicaciones en colaboración con investigadores/as de Eli Lilly and Company (6)
2022
-
Effect of disease related biases on the subjective assessment of social functioning in Alzheimer's disease and schizophrenia patients
Journal of Psychiatric Research, Vol. 145, pp. 302-308
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2021
-
Genetic underpinnings of sociability in the general population
Neuropsychopharmacology, Vol. 46, Núm. 9, pp. 1627-1634
2019
-
A quantitative approach to neuropsychiatry: The why and the how
Neuroscience and Biobehavioral Reviews, Vol. 97, pp. 3-9
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114
2013
-
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Schizophrenia Research, Vol. 150, Núm. 2-3, pp. 328-333